Regencell Bioscience (RGC) P/E (2021 - 2026)
Regencell Bioscience (RGC) P/E from Jul 16, 2021 to Jul 21, 2026. The TTM Regencell Bioscience (RGC) P/E is -837.04. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Regencell Bioscience (RGC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -837.04 | -71.14% |
| 2025 | -2.90K | +19302.66% |
| 2024 | -14.95 | -35.77% |
| 2023 | -23.28 | -52.22% |
| 2022 | -48.71 | -79.35% |
| 2021 | -235.94 | N/A |
Comparison Regencell Bioscience (RGC) P/E with competitors
Regencell Bioscience (RGC) P/E is -837.04.